PRISM BioLab Co.,LTD

TSE:206A Stock Report

Market Cap: JP¥12.5b

PRISM BioLabLTD Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Dai Takehara

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership2.0%
Management average tenureno data
Board average tenure2.8yrs

Recent management updates

Recent updates

CEO

Dai Takehara (61 yo)

no data

Tenure

Mr. Dai Takehara is President, Chief Executive Officer & Director of PRISM BioLab Co.,LTD. since December 2016 and serves its Chairperson. He served as Chief Financial Officer at PRISM Pharma Co.,Ltd.Befo...

Board Members

NamePositionTenureCompensationOwnership
Dai Takehara
Chairmanno datano data2.02%
¥ 251.9m
Michihiro Maeda
GM of Administration2.4yrsno datano data
Hyi-Man Park
Head of the Research & Development Department & Director2.8yrsno datano data
Teruhisa Tajima
Auditor6.2yrsno datano data
Shi Yin Foo
Member of Scientific Advisory Boardno datano datano data
Doriano Fabbro
Member of Scientific Advisory Boardno datano datano data
Hiroshi Nagabukuro
Member of Scientific Advisory Boardno datano datano data
Dean Rigel
Member of Scientific Advisory Boardno datano datano data
Hiromi Furushima
Independent Outside Director2.6yrsno datano data
Yuji Ishiguro
Chairperson of Audit & Supervisory Board Member2.8yrsno datano data
Kiichiro Kawada
Auditor3.6yrsno datano data
Toshinobu Mamiya
Auditor1.6yrsno datano data

2.8yrs

Average Tenure

58yo

Average Age

Experienced Board: 206A's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.